Cancer News
  • Home
  • About
Sign in Subscribe

Dan Manning

Dan Manning
Colonoscopy Decision Aid for Older Adults

project-idea

Colonoscopy Decision Aid for Older Adults

Elderly patients with prior adenomas face very low absolute colorectal cancer risk relative to competing mortality risks — yet surveillance colonoscopy is still widely recommended as routine, even in patients where the procedure's risks and burdens may outweigh realistic cancer prevention benefits.

By Dan Manning 13 Apr 2026
Home Radon Cancer Risk Calculator for Women

project-idea

Home Radon Cancer Risk Calculator for Women

High residential radon was linked to a 30% higher ovarian cancer risk in postmenopausal women — extending radon's known cancer risk beyond lung cancer and providing new evidence that home radon testing has broader cancer prevention relevance for women.

By Dan Manning 13 Apr 2026
HPV Vaccination Equity Tracker for Males

project-idea

HPV Vaccination Equity Tracker for Males

Large-scale evidence now confirms the 9-valent HPV vaccine cuts cancer risk in males — yet male HPV vaccination rates lag significantly behind female rates in most countries, creating a preventable cancer burden that could be visualized and addressed through data-driven advocacy.

By Dan Manning 13 Apr 2026
CA19-9 Beyond the Biomarker: Patient Education Hub

project-idea

CA19-9 Beyond the Biomarker: Patient Education Hub

CA19-9 — the blood test every pancreatic cancer patient gets — is not just a passive indicator of disease; it actively promotes liver metastasis by helping tumor cells stick to liver blood vessels via E-selectin. This mechanistic insight has immediate implications for how patients and clinicians…

By Dan Manning 13 Apr 2026
Lung Cancer Organoid Model Registry

project-idea

Lung Cancer Organoid Model Registry

Patient-derived organoids that faithfully recapitulate keratinizing squamous cell carcinoma histology — including spontaneous keratin pearl formation — fill a critical gap in LUSC preclinical modeling, but these rare models are scattered across individual labs with no shared registry.

By Dan Manning 13 Apr 2026
GBM Spatial Heterogeneity Drug Sensitivity Portal

project-idea

GBM Spatial Heterogeneity Drug Sensitivity Portal

Neurosphere cultures from different regions of the same GBM tumor show completely different drug sensitivities, yet standard drug screening uses single-biopsy cell lines — meaning published drug sensitivity data for GBM may be systematically misleading about what would work in the whole tumor.

By Dan Manning 13 Apr 2026
Viral-Cancer Molecular Mimicry Atlas

project-idea

Viral-Cancer Molecular Mimicry Atlas

Common cold virus antibodies accidentally target hepatocellular carcinoma via molecular mimicry with ASPH — revealing that prior viral infection history may create natural cancer protection and that viral epitopes could be engineered into therapeutic cancer vaccines.

By Dan Manning 13 Apr 2026
Oncolytic Virus Response Signature Database

project-idea

Oncolytic Virus Response Signature Database

RP1 oncolytic virus induces two molecularly distinct CD8+ T cell populations — progenitor-like precursors and terminal effectors — and a precursor-associated gene signature correlates with clinical response to RP1 plus PD-1 blockade in real melanoma patients, making this a candidate predictive…

By Dan Manning 13 Apr 2026
PancreAI: Morphology-to-Molecular Subtype Classifier

project-idea

PancreAI: Morphology-to-Molecular Subtype Classifier

Four morphological classes of pancreatic cancer (glandular, cribriform, solid, squamous) each have distinct transcriptomic programs and clinical implications — meaning what a pathologist sees under a microscope encodes actionable molecular information that could guide treatment decisions without…

By Dan Manning 13 Apr 2026
Rare KRAS-Mutant Cancer Clinical Trial Finder

project-idea

Rare KRAS-Mutant Cancer Clinical Trial Finder

KRAS inhibitors showed dramatic efficacy in appendiceal adenocarcinoma — a rare cancer with almost no approved treatments — and six real patients with heavily pre-treated disease responded, demonstrating that KRAS-mutant rare cancers outside the mainstream (colon, lung, pancreatic) may be…

By Dan Manning 13 Apr 2026
SCLC DLL3 Biomarker Expression Predictor

project-idea

SCLC DLL3 Biomarker Expression Predictor

POU2F1 acts as the master transcriptional activator of DLL3 in SCLC — meaning DLL3 expression levels, which determine whether patients respond to DLL3-targeted therapies like tarlatamab, are now mechanistically explainable and potentially predictable from upstream transcription factor activity.

By Dan Manning 13 Apr 2026
DMG Drug Repurposing Navigator

project-idea

DMG Drug Repurposing Navigator

FDA-approved SSRIs synergize with CDK9 inhibitors to kill diffuse midline glioma cells — meaning drugs that are safe, cheap, brain-penetrant, and already FDA-approved may have immediate translational potential in a childhood brain cancer with no effective treatments.

By Dan Manning 13 Apr 2026
See all
Cancer News
  • Sign up
Powered by Ghost

Cancer News

AI-powered cancer research digest and ideas, published daily